Harnessing Electromagnetic Fields: Downregulating Inflammation and Powering Immunity with Bioelectric Medicine

“Inflammation has a master switch. The interesting engineering question is whether a field can help turn the volume down without silencing the system.”

— Nev Zubcevik, DO, Co-founder & Chief Medical Officer

To understand why electromagnetic fields are studied in the context of inflammation, it helps to look at the molecular control room. A growing body of research examines how electromagnetic and pulsed electromagnetic fields interact with inflammatory signaling — including the cytokines IL-6 and TNF-alpha and, critically, the transcription factor NF-kB. NF-kB is a master regulator of inflammation: when it is overactive, it drives the chronic inflammation and impaired regeneration seen across many diseases.

From an engineering standpoint, a master regulator is an attractive target. Influence it skillfully and you can affect a whole downstream cascade rather than chasing each mediator individually. The hard part — and the part I want to be precise about — is turning the volume down without silencing a system the body genuinely needs.

Effects on immune cells

The research summarized in this area reports effects on immune cells themselves. Fields have been studied in connection with macrophage activation and polarization — the process by which these cells shift between inflammatory and reparative roles — and with modulation of lymphocyte activity. If fields can nudge immune cells toward repair-oriented behavior at the right moment, that is mechanistically interesting and worth rigorous study.

A visualization of an electromagnetic field. “Fields let us reach the body without touching it. That is a profound shift in how we think about delivering care.”

— Ken Mayer, Co-founder & Chief Executive Officer

There is also clinical-evidence context to acknowledge plainly. Systematic review data on osteoarthritis patients treated with PEMF is part of the evidence discussed in this space. I cite it as context, not as a sweeping claim — osteoarthritis is one well-studied setting, and extrapolating beyond the data is precisely the error good engineering avoids.

Dynamic dosing within safety limits

What distinguishes an advanced platform is dynamic, real-time tuning of waveform and dose — always framed within field-strength safety considerations. A fixed dose ignores that inflammation changes over time; a system that adjusts to tissue-response metrics can, in principle, deliver the right amount at the right moment and no more.

“The promise here is reach, supporting the body's own systems through signals rather than substances.”

— Nev Zubcevik, DO, Co-founder & Chief Medical Officer

This is the heart of Electrome's integrated PEMF architecture: tuning field exposure in real time based on how the tissue responds. The long-horizon hope is that electromagnetic modulation can support traditional therapeutics and contribute to regeneration and immune repair — a drug-free complement, studied with the seriousness the claim demands.

Immune cells viewed under the microscope.